Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic

Introduction: Cell-free DNA (cfDNA) analysis offers a non-invasive method to identify sensitising and resistance mutations in advanced Non-Small Cell Lung Cancer (NSCLC) patients. Next-generation sequencing (NGS) of circulating free DNA (cfDNA) is a valuable tool for mutations detection and disease′...

Full description

Bibliographic Details
Main Authors: Maria Gabriela O. Fernandes, Catarina Sousa, Joana Pereira Reis, Natália Cruz-Martins, Conceição Souto Moura, Susana Guimarães, Ana Justino, Maria João Pina, Adriana Magalhães, Henrique Queiroga, José Agostinho Marques, José Carlos Machado, José Luís Costa, Venceslau Hespanhol
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
lung cancer
adenocarcinoma
liquid biopsy
cell-free DNA
tumour-free DNA
next-generation sequencing
Online Access:https://www.mdpi.com/2073-4409/10/8/1912

Internet

https://www.mdpi.com/2073-4409/10/8/1912

Similar Items